SLC1A2 and ischemic stroke: Huang et al. (2021) showed that MSC-Exos prevented the decrease in GLT-1 and miR-124 expression and increased pS6 expression in astrocytes after oxygen-glucose deprivation/reperfusion. This study suggests that MSC-Exos have therapeutic potential against ischemic stroke by regulating GLT-1 expression, with miR-124 and the mTOR pathway playing a role (Huang W. et al., 2023).